PARP14 and neoplasm: This could reflect a more potent suppression achieved by the inhibitor compared to knockdown but may also reflect the combined effect of antagonising PARP14 in tumour and host cells, as PARP14 is expressed in multiple immune cells and other normal cell types13,14,47.